Literature DB >> 21029945

Surgical resection for patients with mucinous bronchioloalveolar carcinoma.

Souichi Oka1, Takeshi Hanagiri, Hidetaka Uramoto, Tetsuro Baba, Masaru Takenaka, Manabu Yasuda, Kenji Ono, Tomoko So, Mitsuhiro Takenoyama, Kosei Yasumoto.   

Abstract

BACKGROUND: The clinical features of mucinous bronchioloalveolar carcinoma (BAC) have remained unclear due to the low incidence of this disease. This study investigated the clinicopathological features and the surgical outcome in patients with mucinous BAC.
METHODS: We clinicopathologically evaluated 782 patients who underwent resection for nonsmall cell carcinoma between 1999 and 2008, of whom, 13 (1.6%) demonstrated to have mucinous BAC.
RESULTS: The patients with mucinous BAC included six men and seven women. The mean age was 69.1 years (range: 55-78 years). Eight patients (61.5%) had a smoking habit. No patients had any subjective symptoms. The tumour diameter ranged from 1.2 cm to 10 cm. The surgical procedures included 11 lobectomies, and two partial resections of affected lobes. The pathological stage was IA in eight patients, IB in two, IIA in two, and IIIA in one. None of the patients had lymph node metastases or lymphovascular invasion. The overall postoperative 5-year survival rate was 52.5%. The 5-year survival rate according to tumour diameter was 100% in patients with tumours ≤ 3 cm, and 25.1% in patients with tumours > 3 cm. Two patients died due to pulmonary metastases, and one died from carcinomatous pleuritis and pulmonary metastases.
CONCLUSION: Patients with small mucinous BAC (≤ 3 cm) in diameter showed excellent prognosis after surgical resection. However, mucinous BAC > 3 cm in diameter tended to recur with pulmonary metastasis.
Copyright © 2010 Asian Surgical Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029945     DOI: 10.1016/S1015-9584(10)60015-2

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  9 in total

Review 1.  Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.

Authors:  Swaroop Revannasiddaiah; Priyanka Thakur; Bhaskar Bhardwaj; Sridhar Papaiah Susheela; Irappa Madabhavi
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.

Authors:  Long Jiang; Weiqiang Yin; Guilin Peng; Wei Wang; Jianrong Zhang; Yang Liu; Shengyi Zhong; Qihua He; Wenhua Liang; Jianxing He
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

Review 3.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

4.  Differential diagnosis of pulmonary nodular mucinous adenocarcinoma and tuberculoma with dynamic CT: a retrospective study.

Authors:  Yue-Hui Yin; Yuan-Gang Qi; Bing Wang
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 3.005

5.  Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study.

Authors:  Seok Whan Moon; Si Young Choi; Mi Hyoung Moon
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

6.  Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report.

Authors:  ZhenGuang Wang; MingMing Yu; YueHua Chen; Yan Kong
Journal:  J Med Case Rep       Date:  2017-07-27

7.  Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.

Authors:  Soohyun Hwang; Joungho Han; Misun Choi; Myung-Ju Ahn; Yong Soo Choi
Journal:  J Pathol Transl Med       Date:  2016-10-16

8.  Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database.

Authors:  Yadong Wang; Jichang Liu; Cuicui Huang; Yukai Zeng; Yong Liu; Jiajun Du
Journal:  BMC Cancer       Date:  2021-02-10       Impact factor: 4.430

9.  A novel nomogram to predict the overall survival of patients with colloid adenocarcinoma of the lung.

Authors:  Jun Zhang; Deruo Liu
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.